SINGLE ANTIPLATELET THERAPY
Clinical trials for SINGLE ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new SINGLE ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for SINGLE ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart stent patients: could a tailored blood thinner dose reduce risks?
Disease control Recruiting nowThis study looks for the safest and most effective dose of blood thinners (P2Y12 inhibitors) for people who have had a heart stent placed. About 355 participants will try different doses to find one that keeps blood clotting at a healthy level—not too high (which can cause clots)…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as using two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 partici…
Matched conditions: SINGLE ANTIPLATELET THERAPY
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 11, 2026 20:40 UTC